Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Subjects:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

Subjects:

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Subjects:

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

Subjects:

Six weeks of voluntary wheel running decreases 5-HT_2C mRNA expression in the medial dorsal striatum. by Benjamin N. Greenwood (295216)

CK2α decreases CLK transcription factor activity. by Áron Szabó (450885)

Overexpression of Lethe in RAW macrophage cells decreases ROS production. by Carlos Zgheib (311460)

CMV infection decreases TER of polarized HCoEpiC. by Ekaterina Maidji (3797899)

Processive receptor methylation compromises adaptation and decreases signaling noise. by William Pontius (460803)

“…(C) Increasing processivity also decreases the magnitude of fluctuations in <i>a</i>(<i>t</i>) in the adapted state around the mean value <i>a</i>₀. …”

Decreased TORC1 activates HPK-1 to extend longevity. by Ritika Das (4514968)

BECN1 knockdown and BCL-W/BCL2 co-inhibition decreases cell proliferation through increased apoptosis in resistant cells. by Anatasha C. Crawford (255140)

Mean Decrease in Margin (MDM) variable importance. by Yuliya V. Karpievitch (259460)

Decrease in number of activated macrophages in demyelinated nerves subjected to 1hr ES. by Nikki A. McLean (643606)

“…Note: ES results in a significant decrease in the ED-1 IF 10d post-LPC (5d post-ES; K) and 12d post-LPC (7d post-ES; N) relative to LPC only in a pattern suggestive of movement toward lateral edges and egress (arrow). …”

HC-070 decreases anxiety in a standard EPM. by Stefan Just (4811358)